SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-113899
Filing Date
2015-03-31
Accepted
2015-03-31 14:46:08
Documents
3
Period of Report
2015-03-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d898415d8k.htm 8-K 17626
2 EX-99.1 d898415dex991.htm EX-99.1 17243
3 EX-99.2 d898415dex992.htm EX-99.2 110371
  Complete submission text file 0001193125-15-113899.txt   146602
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52062 | Film No.: 15738557
SIC: 2834 Pharmaceutical Preparations